Kinetic Characterization of Fragment Binding in AmpC β-lactamase by High-throughput Molecular Simulations
Overview
Medical Informatics
Affiliations
Small molecules used in fragment-based drug discovery form multiple, promiscuous binding complexes difficult to capture experimentally. Here, we identify such binding poses and their associated energetics and kinetics using molecular dynamics simulations on AmpC β-lactamase. Only one of the crystallographic binding poses was found to be thermodynamically favorable; however, the ligand shows several binding poses within the pocket. This study demonstrates free-binding molecular simulations in the context of fragment-to-lead development and its potential application in drug design.
Greisman J, Willmore L, Yeh C, Giordanetto F, Shahamadtar S, Nisonoff H J Chem Inf Model. 2023; 63(9):2644-2650.
PMID: 37086179 PMC: 10170502. DOI: 10.1021/acs.jcim.3c00236.
Solvents to Fragments to Drugs: MD Applications in Drug Design.
Defelipe L, Arcon J, Modenutti C, Marti M, Turjanski A, Barril X Molecules. 2018; 23(12).
PMID: 30544890 PMC: 6321499. DOI: 10.3390/molecules23123269.
Bernetti M, Cavalli A, Mollica L Medchemcomm. 2018; 8(3):534-550.
PMID: 30108770 PMC: 6072069. DOI: 10.1039/c6md00581k.
Dynamic Docking: A Paradigm Shift in Computational Drug Discovery.
Gioia D, Bertazzo M, Recanatini M, Masetti M, Cavalli A Molecules. 2017; 22(11).
PMID: 29165360 PMC: 6150405. DOI: 10.3390/molecules22112029.
Predicting allosteric mutants that increase activity of a major antibiotic resistance enzyme.
Latallo M, Cortina G, Faham S, Nakamoto R, Kasson P Chem Sci. 2017; 8(9):6484-6492.
PMID: 28989673 PMC: 5628580. DOI: 10.1039/c7sc02676e.